DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Bethesda North Marriott Hotel and Conference Center

2019 年 02 月 28 日 7:00 上午 - 2019 年 03 月 01 日 3:00 下午

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Advertising and Promotion Regulatory Affairs Conference

Session 13: Delivering Relevant Information to the Customer in the Age of Digital

Session Chair(s)

Mark  Bard, MBA, MHA

Mark Bard, MBA, MHA

Founder

Digital Health Coalition, United States

Customers (patients, caregivers, and health professionals) expect pharmaceutical and disease content that is aligned with their reality of living in a “digital first” world. They want relevant content and information when, where, and how they want it. Meeting the needs of the digital patient and online health professional has been a challenge for many pharmaceutical companies. This session will discuss online and digital content, targeting, and promotion in a digital world. Additional topics include the challenges of pharmaceutical content in a mobile first world, industry benchmarks, data and privacy concerns, and how digital can support multi-channel and traditional marketing campaigns.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the difference between customer expectations with regard to pharmaceutical information they access online and what is delivered overall
  • Discuss what companies and brands are delivering relevant content from the customer perspective
  • Describe practical strategies for brands to incorporate customer feedback into brand and market plans

    Speaker(s)

    Mark  Bard, MBA, MHA

    Speaker

    Mark Bard, MBA, MHA

    Digital Health Coalition, United States

    Founder

    Rosemarie  Carey

    Rosemarie Carey

    AstraZeneca Pharmaceuticals LP, United States

    Director, Promotional Regulatory Affairs

    Joe  Shields

    Speaker

    Joe Shields

    Health Accelerators, LLC, United States

    President & Co-founder

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。